<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36149977</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of plastic surgery</Title><ISOAbbreviation>Ann Plast Surg</ISOAbbreviation></Journal><ArticleTitle>Hyperosmolar Hyperglycemic Crisis After Burn Injury in a Patient With Advanced Amyotrophic Lateral Sclerosis: A Case Report.</ArticleTitle><Pagination><StartPage>373</StartPage><EndPage>375</EndPage><MedlinePgn>373-375</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SAP.0000000000003293</ELocationID><Abstract><AbstractText>Metabolic disturbance in patients of amyotrophic lateral sclerosis is a rare presentation that might be related to disease progression and outcomes. Hypermetabolic status after major burn injury remains a critical issue in the modern medical care. Here, we present a rare case of a patient sporadic amyotrophic lateral sclerosis who suffered from minor burn injury (8% total body surface area), developing critical hyperosmolar hyperglycemic state during early hospitalization. Newly diagnosed diabetes is established and found related to the underlying disease of this patient. The accumulative metabolic alteration among vulnerable patients of amyotrophic lateral sclerosis and burn injury is noteworthy. Judicious monitoring of fluid and metabolic status helps to prevent the occurrence of acute hyperosmolar hyperglycemic state.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Meng-Wei</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>From the Division of Plastic and Reconstructive Surgery, Department of Surgery.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yu-Tzu</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsueh</LastName><ForeName>Yuan-Yu</ForeName><Initials>YY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Plast Surg</MedlineTA><NlmUniqueID>7805336</NlmUniqueID><ISSNLinking>0148-7043</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="Y">Burns</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006944" MajorTopicYN="Y">Hyperglycemic Hyperosmolar Nonketotic Coma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of interest and sources of funding: none declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36149977</ArticleId><ArticleId IdType="doi">10.1097/SAP.0000000000003293</ArticleId><ArticleId IdType="pii">00000637-202210000-00007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Porter C, Tompkins RG, Finnerty CC, et al. The metabolic stress response to burn trauma: current understanding and therapies. Lancet . 2016;388:1417&#x2013;1426.</Citation></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, et al. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol . 2011;10:75&#x2013;82.</Citation></Reference><Reference><Citation>Blasco H, Lanznaster D, Veyrat-Durebex C, et al. Understanding and managing metabolic dysfunction in amyotrophic lateral sclerosis. Expert Rev Neurother . 2020;20:907&#x2013;919.</Citation></Reference><Reference><Citation>Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care . 2009;32:1335&#x2013;1343.</Citation></Reference><Reference><Citation>Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care . 2014;37:3124&#x2013;3131.</Citation></Reference><Reference><Citation>Ferri A, Coccurello R. What is &#x201c;hyper&#x201d; in the ALS hypermetabolism? Mediators Inflamm . 2017;2017:7821672.</Citation></Reference><Reference><Citation>Shi Y, Park KS, Kim SH, et al. IgGs from patients with amyotrophic lateral sclerosis and diabetes target ca V &#x3b1; 2 &#x3b4;1 subunits impairing islet cell function and survival. Proc Natl Acad Sci U S A . 2019;116:26816&#x2013;26822.</Citation></Reference><Reference><Citation>Despr&#xe9;s JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition . 1993;9:452&#x2013;459.</Citation></Reference><Reference><Citation>Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet . 2009;373:1798&#x2013;1807.</Citation></Reference><Reference><Citation>Gauglitz GG, Herndon DN, Jeschke MG. Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J Burn Care Res . 2008;29:683&#x2013;694.</Citation></Reference><Reference><Citation>Shimizu T, Honda M, Ohashi T, et al. Hyperosmolar hyperglycemic state in advanced amyotrophic lateral sclerosis. Amyotroph Lateral Scler . 2011;12:379&#x2013;381.</Citation></Reference><Reference><Citation>Hemmila MR, Taddonio MA, Arbabi S, et al. Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery . 2008;144:629&#x2013;635; discussion 627&#x2013;635.</Citation></Reference><Reference><Citation>Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ . 2019;365:l1114.</Citation></Reference><Reference><Citation>Shimizu T, Hayashi H, Tanabe H. Energy metabolism of ALS patients under mechanical ventilation and tube feeding [in Japanese]. Rinsho Shinkeigaku . 1991;31:255&#x2013;259.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>